DDR1 and neoplasm: Given that targeting DDR1 kinase activity alone cannot fully block the biological effects mediated by its scaffold function (12, 13), inducing DDR1 degradation may overcome the limitations of DDR1 inhibitor accessibility, thereby effectively inhibiting the growth of DDR1-high expressing tumor cells.